понедельник, 3 июля 2017 г.

Indian pharma sector growth to moderate in next 3 years: ICRA

21 leading players' overall aggregate revenues grew only by 7.4 per cent in FY 2017 as against 10.1 per cent posted in FY 2016, the rating agency said.

0 коммент.:

Отправить комментарий